- Home
- TLSI vs CLAR Comparison
TLSI vs CLAR Comparison
Compare TLSI & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- CLAR
- Stock Information
- Founded
- TLSI 2010
- CLAR 1957
- Country
- TLSI United States
- CLAR United States
- Employees
- TLSI N/A
- CLAR N/A
- Industry
- TLSI Medical Specialities
- CLAR Recreational Games/Products/Toys
- Sector
- TLSI Health Care
- CLAR Consumer Discretionary
- Exchange
- TLSI Nasdaq
- CLAR Nasdaq
- Market Cap
- TLSI 150.0M
- CLAR 136.3M
- IPO Year
- TLSI N/A
- CLAR N/A
- Fundamental
- Price
- TLSI $3.94
- CLAR $3.39
- Analyst Decision
- TLSI Strong Buy
- CLAR Strong Buy
- Analyst Count
- TLSI 5
- CLAR 3
- Target Price
- TLSI $10.90
- CLAR $5.33
- AVG Volume (30 Days)
- TLSI 73.5K
- CLAR 253.2K
- Earning Date
- TLSI 08-12-2025
- CLAR 07-31-2025
- Dividend Yield
- TLSI N/A
- CLAR 3.15%
- EPS Growth
- TLSI N/A
- CLAR N/A
- EPS
- TLSI N/A
- CLAR N/A
- Revenue
- TLSI $35,990,000.00
- CLAR $254,200,000.00
- Revenue This Year
- TLSI $55.39
- CLAR N/A
- Revenue Next Year
- TLSI $54.89
- CLAR $4.23
- P/E Ratio
- TLSI N/A
- CLAR N/A
- Revenue Growth
- TLSI 45.50
- CLAR N/A
- 52 Week Low
- TLSI $3.42
- CLAR $3.02
- 52 Week High
- TLSI $6.04
- CLAR $5.29
- Technical
- Relative Strength Index (RSI)
- TLSI 39.84
- CLAR 49.40
- Support Level
- TLSI $3.42
- CLAR $3.09
- Resistance Level
- TLSI $4.00
- CLAR $3.55
- Average True Range (ATR)
- TLSI 0.36
- CLAR 0.19
- MACD
- TLSI -0.01
- CLAR -0.01
- Stochastic Oscillator
- TLSI 34.75
- CLAR 44.44
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About CLAR Clarus Corporation
Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.